IP Library Patent Application 17426535
Patent Application
App. No. 17/426,535

Nano composite material aiming at acidic sealing zone in osteoclasts and preparation method thereof

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/426,535
Abstract

A nano composite material aiming at an acidic sealing zone in osteoclasts and a preparation method thereof are provided. The nano composite material aiming at the acidic sealing zone in the osteoclasts includes a nano material, bone-targeting molecules, and a compound able to react with the acidic sealing zone in the osteoclasts, wherein: after being modified by the bone-targeting molecules, the nano material is loaded with the compound able to react with the acidic sealing zone in the osteoclasts. Through accurate mature osteoclast targeting and chemically regulated biocascade effects, the osteoclasts are inhibited, which provides a new idea and a new tool for drug therapy of abnormal osteoclast activation.

Claims (9)

1 . A nano composite material aiming at an acidic sealing zone in osteoclasts, comprising a nano material, bone-targeting molecules, and a compound able to react with the acidic sealing zone in the osteoclasts, wherein: after being modified by the bone-targeting molecules, the nano material is loaded with the compound able to react with the acidic sealing zone in the osteoclasts; the nano material is loadable and modifiable; the bone-targeting molecules have an obvious affinity to bone tissues; and the compound able to react with the acidic sealing zone in the osteoclasts is alkalescent or neutral bicarbonate.

2 . The nano composition material, as recited in claim 1 , wherein: the nano material is liposomes, polymer nano particles or mesoporous silicon oxide particles.

3 . The nano composite material, as recited in claim 1 , wherein: the bone-targeting molecules are tetracycline, phosphonate or aspartic acid polypeptide sequences.

4 . The nano composite material, as recited in claim 1 , wherein: the compound able to react with the acidic sealing zone in the osteoclasts is sodium bicarbonate, potassium bicarbonate or ammonium bicarbonate.

5 . The nano composite material, as recited in claim 1 , wherein: the compound able to react with the acidic sealing zone in the osteoclasts is sodium bicarbonate having a concentration of 1 mol/L.

6 . A method for preparing the nano composite material aiming at the acidic sealing zone in the osteoclasts as recited in claim 1 , comprising steps of: cross-linking the loadable and modifiable nano material with the bone-targeting molecules; dissolving in chloroform with lecithin and cholesterol, and controlling a pH value to 8.0-8.4; at a room temperature, magnetically stirring and cross-linking for 24-72 hours; forming a membrane in a rotary evaporator; adding a solution to be loaded, and shaking for hydration; ultrasonically emulsifying, and dialyzing; wherein: a molar ratio of the loadable and modifiable nano material to the bone-targeting molecules is 1:1-1:2.

7 . The method, as recited in claim 6 , wherein: a functionalized molecule in the loadable and modifiable nano material is functionalized phospholipid; after cross-linking with the bone-targeting molecules, bone-targeting functionalized phospholipid is obtained.

8 . The method, as recited in claim 6 , wherein: the step of “ultrasonically emulsifying” specifically comprises steps of: turning on for 1-2 seconds with a power of 30-70%, then turning off for 2-3 seconds, and repeating for 5-20 minutes; and the step of “dialyzing” lasts for 1-3 days.

9 . The method, as recited in claim 7 , wherein: the functionalized phospholipid is DSPE-PEG-NHS; and the bone-targeting molecules are tetracycline (TC).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2025
From: MIANO, ALESSANDRO, DR.; MUKHANOV, OLEG, DR.
To: SEEQC INC.
Reel/Frame 073323/0161 →